On August 6, 2020 Protalix BioTherapeutics, Inc. (NYSE American: PLX) (TASE: PLX), a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its proprietary ProCellEx plant cell-based protein expression system, reported that Dror Bashan, the Company’s President and Chief Executive Officer, and Eyal Rubin, the Company’s Sr. Vice President and Chief Financial Officer, will participate in the BTIG Virtual Biotechnology Conference (Press release, Protalix, AUG 6, 2020, View Source [SID1234563209]). The conference is taking place virtually on Monday, August 10 through Tuesday, August 11.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Mr. Bashan will provide a corporate presentation in a fireside chat format on Monday, August 10 at 2:00 pm ET. A live webcast of the fireside chat will be available at www.protalix.com, on the event calendar page under the Investors tab and at the following link: View Source A replay of the webcast will be available for at least 15 days following the presentation.